Liuyin Chen

Liuyin Chen

Auto-generated profile, based on publicly available information

Liuyin Chen

The First Affiliated Hospital of Guangxi Medical University, Nanning, China

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 September 2022 in Dose-Response
Verified
Journal Article
Open access
LDLin Deng
Lin Deng
HWHousheng Wang
Housheng Wang
TFTing Fan
Ting Fan
LCLiuyin Chen
Liuyin Chen
ZSZhiling Shi
Zhiling Shi
KHKai Hu
Kai Hu
Objective: Transfer RNA-derived small RNAs (tsRNAs) are a novel type of non-coding RNA with various regulatory functions. They are associated with oxidative stress in various diseases, but their potential functions in radiation-induced lung injury (RILI) remain uncertain. Methods: To explore the role of tsRNAs in RILI, we used X-rays to irradiate human bronchial epithelial cells and examined the expression profile of altered tsRNAs by RNA sequencing and bioinformatics analysis. Sequencing results were verified by qRT-PCR. tsRNA functions were explored using several methods, including CCK-8, reactive oxygen species (ROS) assays, cell transfection, and western blotting. Results: Eighty-six differentially expressed tRNA-derived fragments (tRFs) were identified: 64 were upregulated, and 22 were downregulated. Among them, the regulation of tRF-Gly-GCC, associated with oxidative stress, may be mediated by the inhibition of cell proliferation, promotion of ROS production, and apoptosis in the occurrence and development of RILI. A Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis suggested that the underlying molecular mechanism may involve the PI3K/AKT and the FOXO1 signaling pathways. Conclusion: Our findings provide new insights into the molecular mechanisms underpinning RILI, advancing the clinical prevention and treatment of this disease.

1 January 2022 in BioMed Research International
Verified
Journal Article
Open access
PDF file
LCLiuyin Chen
Liuyin Chen
ZSZhiling Shi
Zhiling Shi
LDLin Deng
Lin Deng
JWJiangtao Wu
Jiangtao Wu
HWHousheng Wang
Housheng Wang
KHKai Hu
Kai Hu
Bleomycin is a common antitumor agent used to treat many different types of malignancies; however, its main side effect is pulmonary fibrosis. The mechanism of bleomycin‐induced pulmonary fibrosis (BIPF) has not been fully elucidated. Therefore, to further explore the molecular mechanisms of BIPF, we screened for microRNA (miRNA) and mRNA expression obtained from BIPF samples from the Gene Expression Omnibus database. Subsequently, we identified the differentially expressed miRNAs and genes that overlapped with the differentially expressed miRNAs target genes, predicted by using the miRWalk database selected as a candidate. The candidate genes were visualized based on Gene Ontology and the Kyoto Encyclopedia of Genes and Genomes analyses. A protein‐protein interaction network was constructed. Hub differentially expressed genes were selected and corresponding miRNAs to construct a miRNA‐mRNA regulation network. Then, we chose three key miRNAs to study their regulatory relationship in bleomycin‐induced pulmonary fibrosis. Finally, mouse lung epithelial cells TC‐1 and MLE‐12 were treated with bleomycin with qPCR to validate the results of three important hub genes and all key miRNAs. And dual‐luciferase report experiment was carried out to verify the interaction of mmu‐miR‐1946a and serpina3n. The results revealed that the imbalance of matrix metalloproteinase‐9 (MMP‐9) and tissue inhibitor of metalloproteinase‐1 (TIMP‐1) plays a pivotal role in the occurrence and development of BIPF. In addition, Serpina3n and mmu‐miR‐1946a were proved interaction and may be involved in the regulation of the balance between MMP‐9 and TIMP‐1. The experimental results also verify the analysis. Our findings provide new insights into the key mediators and pathways related to the molecular mechanisms of BIPF.